✦ LIBER ✦

Cancer Immune Therapy || T Cells in Tumor Immunity

✍ Scribed by Stuhler, Gernot; Walden, Peter

Publisher: Wiley
Year: 2002
Tongue: German
Weight: 163 KB
Volume: 10.1002/3527600795
Category: Article
ISBN: 3527600795
DOI: 10.1002/3527600795.ch4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cancer Immune Therapy || Immune Cells in

Cancer Immune Therapy || Immune Cells in the Tumor Microenvironment

✍ Stuhler, Gernot; Walden, Peter 📂 Article 📅 2002 🏛 Wiley 🌐 German ⚖ 494 KB 👁 1 views

Cancer Immune Therapy || Hybrid Cell Vac

Cancer Immune Therapy || Hybrid Cell Vaccination for Cancer Immune Therapy

✍ Stuhler, Gernot; Walden, Peter 📂 Article 📅 2002 🏛 Wiley 🌐 German ⚖ 169 KB 👁 2 views

Cancer Immune Therapy || Serological Det

Cancer Immune Therapy || Serological Determinants on Tumor Cells

✍ Stuhler, Gernot; Walden, Peter 📂 Article 📅 2002 🏛 Wiley 🌐 German ⚖ 113 KB 👁 1 views

Cancer Immune Therapy || Interleukinâ1

Cancer Immune Therapy || Interleukinâ10 in Cancer Immunity

✍ Stuhler, Gernot; Walden, Peter 📂 Article 📅 2002 🏛 Wiley 🌐 German ⚖ 174 KB

Cancer Immune Therapy || Search for Univ

Cancer Immune Therapy || Search for Universal TumorâAssociated T Cell Epitopes

✍ Stuhler, Gernot; Walden, Peter 📂 Article 📅 2002 🏛 Wiley 🌐 German ⚖ 139 KB

Cancer Immune Therapy || Glossary

✍ Stuhler, Gernot; Walden, Peter 📂 Article 📅 2002 🏛 Wiley 🌐 German ⚖ 103 KB

a 2 -Macroglobulin A serum protease inhibitor with a broad range of specificities which blocks members of all four known classes of endopeptidases. It contains a unique thiol ester group which, when cleaved by the proteases, results in a covalent bond between protease and inhibitor. Concordantly, th